Skip to main content

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Actavis Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (11)

Date

2017 (11)

Search

Sponsor content

11 result(s) found, displaying 1 to 10

RISEDRONATE-GA risedronate sodium 35mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE risedronate sodium 5mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE risedronate sodium 30mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE risedronate sodium 35mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE risedronate sodium 75 mg film-coated tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE ONCE-A-MONTH risedronate sodium 150 mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE COMBI risedronate sodium 35mg and calcium carbonate 1250mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE COMBI D risedronate sodium 35mg tablet / supplemental 2500 mg calcium carbonate/22 microgram colecalciferol sachet composite pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE EC ONCE-A-WEEK risedronate sodium 35mg enteric-coated tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd
ACTONATE EC COMBI risedronate sodium 35mg enteric-coated tablet and calcium carbonate 1250mg tablet blister pack Cancelled under s30(1)(c) of the Act

13 April 2017

Cancellation by sponsor

Requested by Actavis Pty Ltd

Pages

Current page 1
Page 2
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia